BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2642208)

  • 1. [Tumor markers and their use in gynecologic oncology].
    Durdević S; Segedi D
    Med Pregl; 1989; 42(11-12):457-60. PubMed ID: 2642208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor markers in gynecology].
    Fuith LC; Artner-Dworzak E; Daxenbichler G
    Wien Klin Wochenschr; 1989 Jul; 101(14):489-91. PubMed ID: 2672608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor markers in gynecological cancer].
    Orbo A
    Tidsskr Nor Laegeforen; 1996 Oct; 116(24):2886-8. PubMed ID: 8975404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor markers in gynecology. General review].
    Briese V; Strache RR
    Zentralbl Gynakol; 1988; 110(5):257-66. PubMed ID: 3287800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The place of tumor markers in breast and gynecologic neoplasms].
    Gosselin P; Cazin JL; Demaille MC; Sulman C
    Rev Fr Gynecol Obstet; 1988; 83(7-9):535-40. PubMed ID: 3057569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical relevance of tumor markers].
    Lamerz R
    Wien Klin Wochenschr; 1989 Jul; 101(14):464-72. PubMed ID: 2672606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE; Cracchiolo BM; Cole LA
    Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities and evaluation of the use of tumor markers in gynecologic oncology. 1. Biochemical parameters].
    Elling D; Bartel U; Götze W
    Zentralbl Gynakol; 1987; 109(16):994-1004. PubMed ID: 3673328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
    Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer].
    Kreienberg R
    Gynakologe; 1989 Feb; 22(1):55-62. PubMed ID: 2653979
    [No Abstract]   [Full Text] [Related]  

  • 11. Knowledge of tumor markers and the psychological consequences of tumor marker sampling in patients with gynecologic cancers.
    Mayerhofer K; Bodner K; Aktas C; Schindl M; Kaider A; Leodolter S; Joura EA; Kainz C
    Anticancer Res; 2000; 20(2B):1281-4. PubMed ID: 10810435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors.
    Ulsperger E; Karrer K
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():33-43. PubMed ID: 3074225
    [No Abstract]   [Full Text] [Related]  

  • 14. The beta-core fragment of human chorionic gonadotropin: biochemical background and clinical application.
    Schutter EM; Mulder C; van Kamp GJ; Kenemans P
    Anticancer Res; 1997; 17(2B):1255-72. PubMed ID: 9137483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D; Hirasawa A; Susumu N
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quagmire of hCG and hCG testing in gynecologic oncology.
    Muller CY; Cole LA
    Gynecol Oncol; 2009 Mar; 112(3):663-72. PubMed ID: 19007977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Squamous cell carcinoma antigen--a useful tumor marker for gynecologic squamous cell cancers?].
    Neunteufel W; Tatra G; Reinthaller A; Bieglmayer C
    Gynakol Rundsch; 1988; 28 Suppl 2():201-2. PubMed ID: 3234918
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progress in the study of the uses of proteomics in gynecologic oncology].
    Yang YS; Chen JL; Wan XP
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):425-7. PubMed ID: 15312333
    [No Abstract]   [Full Text] [Related]  

  • 19. [ What kind of follow-up after cancer of the breast or genital organs?].
    Delaloye JF
    Rev Med Suisse Romande; 1994 Sep; 114(9):789-91. PubMed ID: 7939111
    [No Abstract]   [Full Text] [Related]  

  • 20. [Basic and clinical study of oncofetal antigen in the field of gynecology].
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Aug; 39(8):1204-46. PubMed ID: 3451933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.